Related references
Note: Only part of the references are listed.Immunoprophylaxis against respiratory syncytial virus (RSV) with palivizumab in children: a systematic review and economic evaluation
D Wang et al.
HEALTH TECHNOLOGY ASSESSMENT (2014)
Respiratory Syncytial Virus and Recurrent Wheeze in Healthy Preterm Infants
Maarten O. Blanken et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Respiratory Syncytial Virus and Recurrent Wheeze
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Should respiratory care in preterm infants include prophylaxis against respiratory syncytial virus? The case against
David Isaacs
PAEDIATRIC RESPIRATORY REVIEWS (2013)
Respiratory Syncytial Virus-Associated Hospitalizations Among Children Less Than 24 Months of Age
Caroline Breese et al.
PEDIATRICS (2013)
Host Cell Entry of Respiratory Syncytial Virus Involves Macropinocytosis Followed by Proteolytic Activation of the F Protein
Magdalena Anna Krzyzaniak et al.
PLOS PATHOGENS (2013)
Benefit and harm from immunity to respiratory syncytial virus: implications for treatment
Maximillian S. Habibi et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2012)
Cost-effectiveness of potential infant vaccination against respiratory syncytial virus infection in The Netherlands
M. J. Meijboom et al.
VACCINE (2012)
A decade of respiratory syncytial virus epidemiology and prophylaxis: Translating evidence into everyday clinical practice
Bosco A. Paes et al.
CANADIAN RESPIRATORY JOURNAL (2011)
Hot topics in the prevention of respiratory syncytial virus disease
Maximillian S Habibi et al.
Expert Review of Vaccines (2011)
Palivizumab for immunoprophylaxis of respiratory syncytial virus (RSV) bronchiolitis in high-risk infants and young children: a systematic review and additional economic modelling of subgroup analyses
D. Wang et al.
HEALTH TECHNOLOGY ASSESSMENT (2011)
Household Tobacco Smoke and Admission Weight Predict Severe Bronchiolitis in Infants Independent of Deprivation: Prospective Cohort Study
Malcolm G. Semple et al.
PLOS ONE (2011)
Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis
Harish Nair et al.
LANCET (2010)
Cost effectiveness of palivizumab in Spain: an analysis using observational data
Mark J. Nuijten et al.
EUROPEAN JOURNAL OF HEALTH ECONOMICS (2010)
The Role of Immunoprophylaxis in the Reduction of Disease Attributable to Respiratory Syncytial Virus
H. Cody Meissner et al.
PEDIATRICS (2009)
Cost effectiveness of palivizumab for RSV prevention in high-risk children in the Netherlands
Mark Nuijten et al.
JOURNAL OF MEDICAL ECONOMICS (2009)
The cost-effectiveness of palivizumab for respiratory syncytial virus prophylaxis in premature infants with a gestational age of 32-35 weeks: a Canadian-based analysis
Krista L. Lanctot et al.
CURRENT MEDICAL RESEARCH AND OPINION (2008)
Management of acute bronchiolitis: can evidence based guidelines alter clinical practice?
J. Barben et al.
THORAX (2008)
Mortality in children from influenza and respiratory syncytial virus
DM Fleming et al.
JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH (2005)
Palivizumab for preterm infants. Is it worth it?
ND Embleton et al.
ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION (2005)
The clinical and health economic burden of respiratory syncytial virus disease among children under 2 years of age in a defined geographical area
SA Deshpande et al.
ARCHIVES OF DISEASE IN CHILDHOOD (2003)
Palivizumab prophylaxis reduces hospitalization due to respiratory syncytial virus in young children with hemodynamically significant congenital heart disease
TF Feltes et al.
JOURNAL OF PEDIATRICS (2003)
Recent trends in severe respiratory syncytial virus (RSV) among US infants, 1997 to 2000
S Leader et al.
JOURNAL OF PEDIATRICS (2003)
Contribution of RSV to bronchiolitis and pneumonia-associated hospitalizations in English children, April 1995-March 1998
B Müller-Pebody et al.
EPIDEMIOLOGY AND INFECTION (2002)
Potential therapeutic implications of new insights into respiratory syncytial virus disease
PJM Openshaw
RESPIRATORY RESEARCH (2002)
Respiratory syncytial virus prophylaxis - the story so far
EAF Simoes et al.
RESPIRATORY MEDICINE (2002)
Medical progress - Respiratory syncytial virus and parainfluenza virus.
CB Hall
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Bronchiolitis-associated mortality and estimates of respiratory syncytial virus-associated deaths among US children, 1979-1997
DK Shay et al.
JOURNAL OF INFECTIOUS DISEASES (2001)
Nosocomial respiratory syncytial virus infections: The cost-effectiveness and cost-benefit of infection control
KK Macartney et al.
PEDIATRICS (2000)
Share Paper
